Weili Zhao, PhD
Ruijin Hospital
5
4
0
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Depei Wu, PhD
The First Affiliated Hospital of Soochow University
Shared therapeutic areas:
Worked with same sponsors:
Hongmei Jing
Peking University Third Hospital
Shared therapeutic areas:
Worked with same sponsors:
Huilai Zhang
Tianjin Cancer Hospital Airport Hospital
Shared therapeutic areas:
Worked with same sponsors:
Huiqiang Huang, PhD
Sun Yat-sen University
Shared therapeutic areas:
Worked with same sponsors:
Dehui Zou
Hematology Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Zhifeng Li
The First Hospital of Xiamen University
Shared therapeutic areas:
Worked with same sponsors:
Qingyuan Zhang
Harbin Medical University Tumor Hospital
Shared therapeutic areas:
Worked with same sponsors:
heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Jianqiu Wu
Jiangsu Provincial Tumor Hospital
Shared therapeutic areas:
Worked with same sponsors:
Liang Huang, PhD
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
Relmacabtagene Autoleucel in Patients With LBCL
Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL
Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
All 5 trials loaded